Benzo[D]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors
申请人:Hoffman-La Roche Inc.
公开号:US07939535B2
公开(公告)日:2011-05-10
The present invention provides compounds of the general formula (I), having affinity and selectivity for the dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the therapeutic and/or prophylactic treatment of cognitive disorders.
本发明提供了一般式(I)的化合物,具有亲和力和选择性,可与多巴胺D3受体结合,其制备方法,包含它们的制药组合物及其用于治疗和/或预防认知障碍的用途。